Characterization of the colistin (polymyxin E1 and E2) biosynthetic gene cluster
- 1.1k Downloads
Colistin is a mixture of polymyxin E1 and E2, bactericidal pentacationic lipopeptides used to treat infections caused by Gram-negative pathogens such as Pseudomonas aeruginosa and Klebsiella pneumoniae. Industrial production of colistin is obtained by a fermentation process of the natural producer Paenibacillus polymyxa var colistinus. NonRibosomal peptide synthetases (NRPS) coding the biosynthesis of polymyxins A, B and P have been recently described, rendering thereof the improvement of their production possible. However, the colistin biosynthesis pathway was not published so far. In this study, a Paenibacillus alvei has been identified by biochemical (Api 50 CH system) and molecular (16S rDNA sequencing) methods. Its culture supernatant displayed inhibitory activity against Gram-negative bacteria (P. aeruginosa, K. pneumoniae, Salmonella spp.). Two polymyxins, E1 and E2, were recovered from the supernatant and were characterized by high resolution LC–MS. A genomic library (960 clones) was constructed to identify the gene cluster responsible for biosynthesis of polymyxins. Selection of the clones harbouring the sequences of interest was obtained by a simple PCR-based screening. We used primers targeting NRPS sequences leading to the incorporation of amino acids present in polymyxins E. The sequences from three clones of interest were assembled on 50.4 kb. Thus, five open reading frames corresponding to a new NRPS gene cluster of 41 kb were identified. In silico, analyses revealed the presence of three NRPS implicated in the biosynthesis of polymyxins E. This work provides insightful information on colistin biosynthesis and might contribute to future drug developments in this group of antibiotics.
KeywordsPaenibacillus Polymyxin Colistin NRPS Nonribosomal peptide
We thank « l’Association Vaincre La Mucoviscidose » for their financial support.
- Chevrot R, Didelot S, Van den Bossche L, Tambadou F, Caradec T, Marchant P, Izquierdo E, Sopena V, Caillon J, Barthélémy C, Van Schepdael A, Hoogmartens J, Rosenfled E (2013) A novel depsipeptide produced by Paenibacillus alvei 32 isolated from a cystic fibrosis patient. Probiotics Antimicrob Proteins 5:18–25CrossRefGoogle Scholar
- Cochrane SA, Vederas JC (2014) Lipopeptides from Bacillus and Paenibacillus spp.: a gold mine of antibiotic candidates. Med Res Rev. doi: 10.1002/med.21321
- Falagas ME, Kasiakou S, Kofteridis D, Roditakis G, Samonis G (2006) Effectiveness and nephrotoxicity of intravenous colistin for treatment of patients with infections due to polymyxin-only-susceptible (POS) Gram-negative bacteria. Eur J Clin Microbiol Infect Dis 25:596–599CrossRefPubMedGoogle Scholar
- Lee DL, Powers JP, Pflegerl K, Vasil ML, Hancock RE, Hodges RS (2004) Effects of single D-amino acid substitutions on disruption of beta-sheet structure and hydrophobicity in cyclic 14-residue antimicrobial peptide analogs related to gramicidin S. J Pept Res 63:69–84CrossRefPubMedCentralPubMedGoogle Scholar
- Naghmouchi K, Baah J, Hober D, Jouy E, Rubrecht C, Sané F, Drider D (2013) Synergistic effect between colistin and bacteriocins in controlling Gram-negative pathogens and their potential to reduce antibiotic toxicity in mammalian epithelial cells. Antimicrob Agents Chemother 57:2719–2725CrossRefPubMedCentralPubMedGoogle Scholar
- Nation RL, Li J, Cars O, Couet W, Dudley MN, Kaye KS, Mouton JW, Paterson DL, Tam VH, Theuretzbacher U, Tsuji BT, Turnidge JD (2014) Framework for optimisation of the clinical use of colistin and polymyxin B: the Prato polymyxin consensus. Lancet Infect Dis 14:70850–70853Google Scholar
- Niu B, Vater J, Rueckert C, Blom J, Lehmann M, Ru JJ, Chen XH, Wang Q, Borriss R (2013) Polymyxin P is the active principle in suppressing phytopathogenic Erwinia spp. by the biocontrol rhizobacterium Paenibacillus polymyxa M-1. BMC Microbiol 137:1–13Google Scholar
- Olli S, Rangaraj N, Nagaraj R (2013) Effect of selectively introducing arginine and D-amino acids on the antimicrobial activity and salt sensitivity in analogs of human beta-defensins. PLoS One 9:1–10Google Scholar
- Sambrook JF, Russell DW (2001) Molecular cloning: a laboratory manual. Cold Spring Harbor Laboratory Press, New York, p 2100Google Scholar
- Stansly PG (1947) Studies on polymyxin: isolation and identification of Bacillus polymyxa and differentiation of polymyxin from certain known antibiotics. Bacteriol 54:549–556Google Scholar